Bill > S06758

This bill requires healthcare practitioners to discuss specific risks with patients before prescribing a Schedule II controlled substance or an opioid analgesic for pain, expanding on existing requirements to include discussions about addiction, overdose, and the dangers of mixing these drugs with other substances like alcohol or benzodiazepines, and also mandates that the Department of Health develop guidelines for these discussions. Additionally, the bill clarifies the definition of "opioid analgesics" and modifies existing rules to require practitioners to counsel patients on overdose risks and prescribe an opioid antagonist if certain risk factors are present, such as a history of substance use disorder or concurrent use of opioids with sedatives, when prescribing more than a one-week supply of an opioid analgesic outside of specific hospital or hospice settings.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S6758